Wednesday, February 1, 2023
Psychosis is common among patients with Parkinson disease, with more than 50% experiencing hallucinations or delusions at some point in their illness. These symptoms have a substantial impact on patients' and caregivers' quality of life. However, patients and caregivers seldom discuss these symptoms unless they are asked about them. This podcast series explores the burden of PDP, how to recognize and diagnose it, therapeutic considerations, and special considerations for long-term care populations.
Disclaimer
The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Medscape Education© Medscape, LLC
When is it time to treat Parkinson disease psychosis (PDP)? What are the options? Drs Grossberg and Pahwa discuss considerations
in management.
What does Parkinson disease psychosis (PDP) look like? How does it affect patients and caregivers? Drs Grossberg and Larson
discuss the symptoms and burden of PDP.